Cargando…
Possible role of low-dose etoposide therapy for hemophagocytic lymphohistiocytosis by COVID-19
Autor principal: | Takami, Akiyoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216850/ https://www.ncbi.nlm.nih.gov/pubmed/32399895 http://dx.doi.org/10.1007/s12185-020-02888-9 |
Ejemplares similares
-
Reply to the letter by Gaetano Loscocco, Secondary hemophagocytic lymphohistiocytosis, HScore and COVID-19
por: Takami, Akiyoshi
Publicado: (2020) -
The role of etoposide in the treatment of adult patients with hemophagocytic lymphohistiocytosis
por: Zondag, Timo C. E., et al.
Publicado: (2023) -
Secondary hemophagocytic lymphohistiocytosis, HScore and COVID-19
por: Loscocco, Giuseppe G.
Publicado: (2020) -
Hemophagocytic lymphohistiocytosis after COVID-19 vaccination
por: Tang, Liang V., et al.
Publicado: (2021) -
Hemophagocytic lymphohistiocytosis in adults
por: Machaczka, Maciej
Publicado: (2013)